234 related articles for article (PubMed ID: 20702059)
1. The "two-week wait" referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer.
Sharpe D; Williams RN; Ubhi SS; Sutton CD; Bowrey DJ
Eur J Surg Oncol; 2010 Oct; 36(10):977-81. PubMed ID: 20702059
[TBL] [Abstract][Full Text] [Related]
2. The 2-week wait referral system does not improve 5-year colorectal cancer survival.
Zafar A; Mak T; Whinnie S; Chapman MA
Colorectal Dis; 2012 Apr; 14(4):e177-80. PubMed ID: 21920007
[TBL] [Abstract][Full Text] [Related]
3. The "two-week wait" referral pathway is not associated with improved survival for patients with colorectal cancer.
Aslam MI; Chaudhri S; Singh B; Jameson JS
Int J Surg; 2017 Jul; 43():181-185. PubMed ID: 28600231
[TBL] [Abstract][Full Text] [Related]
4. Referral of patients with iron deficiency anaemia under the lower gastrointestinal two-week wait rule.
Shaw AG; Simpson J; Tierney G; Goddard AF; Reynolds JR; Lund JN
Colorectal Dis; 2008 Mar; 10(3):294-7. PubMed ID: 17764534
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of head and neck cancer patients: a comparison between ENT patients referred via the 2 weeks wait pathway and alternative routes in the UK health system.
Wong BYW; Fischer S; Cruickshank HE
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):415-420. PubMed ID: 27416743
[TBL] [Abstract][Full Text] [Related]
6. Impact of 'two-week wait' referral pathway on the diagnosis, treatment and survival in upper and lower gastrointestinal cancers.
Fallon M; Adil MT; Ahmed K; Whitelaw D; Rashid F; Jambulingam P
Postgrad Med J; 2019 Sep; 95(1127):470-475. PubMed ID: 31147396
[TBL] [Abstract][Full Text] [Related]
7. The association between referral source and stage of disease in patients with colorectal cancer.
Bevis PM; Donaldson OW; Card M; Durdey P; Thomas MG; Sylvester PA; Longman RJ
Colorectal Dis; 2008 Jan; 10(1):58-62. PubMed ID: 17477850
[TBL] [Abstract][Full Text] [Related]
8. Detection and survival of colorectal cancer from a 2 week wait service.
Bhangu A; Khan M; Roberts L; Reynolds A; Desai A; Mathew G
Surgeon; 2011 Apr; 9(2):78-82. PubMed ID: 21342671
[TBL] [Abstract][Full Text] [Related]
9. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer.
Spahos T; Hindmarsh A; Cameron E; Tighe MR; Igali L; Pearson D; Rhodes M; Lewis MP
Postgrad Med J; 2005 Nov; 81(961):728-30. PubMed ID: 16272239
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes of elderly patients referred to the lower gastrointestinal 2-week wait service.
Hubbard TJE; Pringle H; Bethune R; McDermott FD
Colorectal Dis; 2021 Jun; 23(6):1434-1443. PubMed ID: 33742557
[TBL] [Abstract][Full Text] [Related]
11. The two-week wait guideline for suspected CNS tumours: a decade analysis.
Hamdan A; Mitchell P
Br J Neurosurg; 2013 Oct; 27(5):642-5. PubMed ID: 23472626
[TBL] [Abstract][Full Text] [Related]
12. Two week waits: What are we waiting for?
Abdelraheim AR; Khairy M; Mohammed M; Lawrence A
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():112-117. PubMed ID: 28609712
[TBL] [Abstract][Full Text] [Related]
13. Comparative outcome of oesophagogastric cancer in younger patients.
Mehta SP; Bailey D; Davies N
Ann R Coll Surg Engl; 2010 Sep; 92(6):515-8. PubMed ID: 20522292
[TBL] [Abstract][Full Text] [Related]
14. The 2-week wait service: a UK tertiary colorectal centre's experience in the early identification of colorectal cancer.
Patel RK; Sayers AE; Seedat S; Altayeb T; Hunter IA
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1408-14. PubMed ID: 25244412
[TBL] [Abstract][Full Text] [Related]
15. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
16. Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study.
Potter S; Govindarajulu S; Shere M; Braddon F; Curran G; Greenwood R; Sahu AK; Cawthorn SJ
BMJ; 2007 Aug; 335(7614):288. PubMed ID: 17631514
[TBL] [Abstract][Full Text] [Related]
17. Knowledge or noise? Making sense of General Practitioners' and Consultant use of 2-week-wait referrals for suspected cancer.
Donnelly C; Hart N; McCrorie AD; Anderson L; Donnelly M; Murchie P; Gavin A
Br J Cancer; 2017 Aug; 117(5):597-603. PubMed ID: 28751756
[TBL] [Abstract][Full Text] [Related]
18. The impact of the two-week wait referral pathway on rectal cancer survival.
Currie AC; Evans J; Smith NJ; Brown G; Abulafi AM; Swift RI
Colorectal Dis; 2012 Jul; 14(7):848-53. PubMed ID: 21920010
[TBL] [Abstract][Full Text] [Related]
19. A study on the routes of referral for patients with colorectal cancer and its affect on the time to surgery and pathological stage.
Trickett JP; Donaldson DR; Bearn PE; Scott HJ; Hassall AC
Colorectal Dis; 2004 Nov; 6(6):428-31. PubMed ID: 15521930
[TBL] [Abstract][Full Text] [Related]
20. The utility of FDG-PET in the preoperative staging of esophageal cancer.
Gananadha S; Hazebroek EJ; Leibman S; Berry H; Osgood L; Shon IH; Pavlakis N; Marx G; Smith GS
Dis Esophagus; 2008; 21(5):389-94. PubMed ID: 19125791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
